TSX/VHI (TSX/VHI)

Toronto Stock Exchange: TSX/VHI · CAD

CA$7.68

+0.15 (+2.0%)· Recorded snapshot

Market cap	486.4M
Revenue (ttm)	127.1M
Net income (ttm)	7.5M
EPS (ttm)	CA$0.12
Shares out	63.3M
P/E (trailing)	64.0x
P/E (forward)	29.3x
Volume	58,131
Beta	0.89

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 127.1M
Net income (ttm): 7.5M
EPS (ttm): CA$0.12
P/E (trailing): 64.0x
P/E (forward): 29.3x
Market cap: 486.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E29.3

P25 n/aP50 n/aP75 n/a

Trailing P/E64

P25 n/aP50 n/aP75 n/a

ROE3.3

P25 n/aP50 n/aP75 n/a

ROIC8.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/VHI indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

CAD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-05
Employees	700
Employees change	200
Employees growth	40%
Enterprise value	CAD 352.8M
Exchange	Toronto Stock Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2010
Industry	Health Information Services
Is primary listing	Yes
ISIN number	CA92847V5018
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Last stock split date	2020-01-06
Last stock split type	Reverse
Market cap	CAD 486.4M
Next earnings date	2026-11-05
Price	CAD 7.68
Price currency	CAD
Sector	Healthcare
SIC code	7370
Stock price date	2026-10-29
Symbol	tsx/VHI
Website	https://www.vitalhub.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	34.24x
Average P/E ratio (3Y)	111.07x
Average P/E ratio (5Y)	132.36x
Earnings yield	1.56%
EV/Earnings	45.88x
EV/EBIT	22.43x
EV/EBITDA	13.29x
EV/FCF	16.58x
EV/Sales	2.7x
FCF / EV yield	6.03%
FCF yield	4.34%
Forward P/E	29.25x
Graham number	3.41925
Graham upside	-54.59%
Lynch fair value	CAD 3.00
Lynch upside	-60.15%
P/(FCF - SBC) ratio	25.61x
P/(OCF - SBC) ratio	24.77x
P/B ratio	1.74x
P/E ratio	63.99x
P/FCF ratio	23.03x
P/OCF ratio	22.35x
P/S ratio	3.75x
Price / tangible book value	6.25x
Price/EBITDA ratio	18.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	12.04%
EBITDA margin	19.79%
Effective tax rate	20.44%
FCF margin	16.3%
Gross margin	80.26%
Operating margin	12.04%
Pretax margin	7.4%
Profit margin	5.89%
Profit per employee	CAD 10,689
Profitable quarters	3
Profitable years	4
Revenue per employee	CAD 181,540
ROA	2.9%
ROA (5Y)	2.76%
ROCE	5.12%
ROE	3.28%
ROE (5Y)	1.91%
ROIC	8.36%
ROIC (5Y)	7.6%
SBC / revenue	1.64%
Tax / revenue	1.51%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	48.69%
EPS growth (Q)	0%
EPS growth (QoQ)	-19.45%
EPS growth 3Y	118.54%
EPS growth years	1
FCF growth	54.06%
FCF growth (Q)	523.15%
FCF growth (QoQ)	591.17%
FCF growth 3Y	41.57%
FCF growth 5Y	54.77%
Gross profit growth	52.59%
Gross profit growth (Q)	30.01%
Gross profit growth 3Y	39.15%
Gross profit growth 5Y	46.85%
Net income growth	51.17%
Net income growth (Q)	10.02%
Net income growth (QoQ)	-17.21%
Net income growth 3Y	148.76%
Net income growth quarters	3
Net income growth years	1
OCF growth	50%
OCF growth (Q)	514.45%
OCF growth (QoQ)	586.55%
OCF growth 3Y	41%
OCF growth 5Y	53.08%
Operating income growth	47.51%
Operating income growth (Q)	27.3%
Operating income growth 3Y	50.99%
Operating income growth 5Y	152.05%
Revenue growth	53.79%
Revenue growth (Q)	33.03%
Revenue growth (QoQ)	-0.53%
Revenue growth 10Y	75.17%
Revenue growth 3Y	39.56%
Revenue growth 5Y	45.65%
Revenue growth quarters	24
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -627,552
Depreciation and amortization	CAD 9.8M
EBIT	CAD 15.3M
EBITDA	CAD 25.1M
EPS	CAD 0.12
FCF per share	CAD 0.33
Financing cash flow	CAD 56.7M
Free cash flow	CAD 20.7M
Free cash flow minus SBC	CAD 18.6M
Gross profit	CAD 102M
Income taxes	CAD 1.9M
Investing cash flow	CAD -101.2M
Net borrowing	CAD -15.9M
Net cash flow	CAD -23.5M
Net income	CAD 7.5M
Operating cash flow minus SBC	CAD 19.3M
Operating income	CAD 15.3M
Revenue	CAD 127.1M
Stock-based compensation	CAD 2.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.07
Book value per share	CAD 4.33
Debt / EBITDA	0.11
Debt / equity	0.01
Debt / FCF	0.14
Goodwill	CAD 110.8M
Interest coverage	122.36
Long-term assets	CAD 203.5M
Long-term liabilities	CAD 24.7M
Net cash (debt)	CAD 133.6M
Net cash / market cap	28.02%
Net cash growth	70.43%
Net debt / EBITDA	-5.31
Net debt / equity	-0.49
Net debt / FCF	-6.45
Piotroski F-Score	6
Property, plant and equipment	CAD 4.2M
Shareholders' equity	CAD 274.2M
Tangible book value	CAD 76.3M
Tangible book value per share	CAD 1.20
Total assets	CAD 381.8M
Total cash	CAD 136.5M
Total debt	CAD 2.9M
Total liabilities	CAD 107.6M
WACC	9.11%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.39
Current assets	CAD 178.3M
Current liabilities	CAD 82.9M
Current ratio	2.15
Inventory turnover	74.68
Net working capital	CAD -40.6M
Quick ratio	2.1
Working capital	CAD 95.4M
Working capital turnover	1.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-14.31%
Shareholder yield	-14.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 7.46
1D price change	1.99%
1M price change	3.52%
1M total return	3.52%
1W price change	-0.65%
1W total return	-0.65%
1Y price change	-33.91%
1Y return CAGR	-33.93%
1Y total return	-33.91%
20-day SMA	CAD 7.46
200-day SMA	CAD 7.63
3M price change	9.93%
3M total return	9.93%
3Y price change	168.07%
3Y return CAGR	38.91%
3Y total return	168.07%
50-day SMA	CAD 7.67
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 11.72
52-week high date	2025-10-29
52-week low	CAD 6.46
52-week low date	2026-07-24
5Y price change	158.98%
5Y return CAGR	20.97%
5Y total return	158.98%
6M price change	-5.45%
6M total return	-5.45%
All-time high	CAD 14.64
All-time high date	2025-08-08
All-time low	CAD 0.80
All-time low date	2017-10-20
Average true range (ATR)	CAD 0.26
Average volume	163.1K
Beta (1Y)	1.37
Beta (2Y)	1.12
Beta (5Y)	0.89
Change from 52-week high	-34.47%
Change from 52-week low	18.89%
Change from all-time high	-47.81%
Change from all-time low	855%
Change from open	1.72%
Day's gap	0.27%
Dollar volume	CAD 446,446
High price	CAD 7.75
Low price	CAD 7.50
Monthly RSI	46.87
Open price	CAD 7.55
Position in 52-week range	72%
Previous close	CAD 7.53
Price vs 150-day SMA	2.4%
Price vs 20-day SMA	2.37%
Price vs 200-day SMA	0.08%
Price vs 50-day SMA	-0.37%
Relative volume	0.36
RSI	53.32
Sharpe ratio	-0.92
Sharpe ratio (3Y)	0.89
Sharpe ratio (5Y)	0.6
Sortino ratio	-1.15
Sortino ratio (3Y)	1.57
Sortino ratio (5Y)	1.08
Volume	58.1K
Weekly RSI	49.59
YTD price change	-19.32%
YTD total return	-19.32%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56M
Shares change (QoQ)	-0.48%
Shares change (YoY)	14.31%
Shares held by insiders	10.71%
Shares held by institutions	36.74%
Shares outstanding	63.3M

Deeper analysis on TSX/VHI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/VHI report

Is a complete TSX/VHI research report available?

No complete published report is available for tsx/VHI (TSX/VHI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/VHI (TSX/VHI)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/VHI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/VHI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/VHI

Frequently asked questions